GSA Capital Partners’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,227
| Closed | -$37K | – | 2089 |
|
|
2024
Q2 | $37K | Sell |
2,227
-7,626
| -77% | -$127K | ﹤0.01% | 1572 |
|
|
2024
Q1 | $171K | Buy |
9,853
+776
| +9% | +$13.5K | 0.01% | 1432 |
|
|
2023
Q4 | $142K | Buy |
+9,077
| New | +$142K | 0.01% | 1372 |
|
|
2023
Q3 | – | Sell |
-955
| Closed | -$75K | – | 1988 |
|
|
2023
Q2 | $75K | Sell |
955
-1,088
| -53% | -$85.4K | 0.01% | 1399 |
|
|
2023
Q1 | $185K | Sell |
2,043
-957
| -32% | -$86.7K | 0.02% | 1271 |
|
|
2022
Q4 | $354K | Sell |
3,000
-375
| -11% | -$44.3K | 0.04% | 820 |
|
|
2022
Q3 | $612K | Buy |
3,375
+982
| +41% | +$178K | 0.08% | 424 |
|
|
2022
Q2 | $215K | Sell |
2,393
-1,658
| -41% | -$149K | 0.03% | 1038 |
|
|
2022
Q1 | $629K | Sell |
4,051
-715
| -15% | -$111K | 0.08% | 394 |
|
|
2021
Q4 | $1.42M | Buy |
+4,766
| New | +$1.42M | 0.18% | 88 |
|